First-in-human phase 1 trial of the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of WSD0922-Fu: Initial report from dose escalation cohort.
Resource Type
Article
Authors
Kizilbash, Sani Haider ; Jaeckle, Kurt A. ; Mrugala, Maciej M. ; Allred, Jacob B. ; Safgren, Stephanie L. ; Lammers, Anita Aracelli ; Zhong, Wei ; Leventakos, Konstantinos ; Mansfield, Aaron Scott ; Shanshal, Mohamed ; Ma, Wen Wee ; Uhm, Joon H. ; Campian, Jian Li ; Ruff, Michael W. ; Sener, Ugur ; Galanis, Evanthia ; Burns, Terry C ; Giannini, Caterina ; Sarkaria, Jann Nagina ; Adjei, Alex A.
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3109-3109, 1p
Subject
Language
ISSN
0732183X